{"id":"f118f4f1c7c8","type":"article","url":"https://hartvaat.nl/2023/09/19/uspstf-screening-op-hypertensieve-zwangerschapsstoornissen-aanbevolen/","title":"USPSTF: screening op hypertensieve zwangerschapsstoornissen aanbevolen","title_en":"Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.","category":"hypertensie","category_label":"Hypertensie","professions":["huisarts"],"tags":["primaire-preventie","zwangerschap-hart"],"journal":"JAMA","doi":"10.1001/jama.2023.16991","source_url":"https://doi.org/10.1001/jama.2023.16991","authors":["Michael J Barry","Wanda K Nicholson","Michael Silverstein","Michael D Cabana","David Chelmow","Tumaini Rucker Coker","Esa M Davis","Katrina E Donahue","Carlos Roberto Jaén","Li Li","Gbenga Ogedegbe","Goutham Rao","John M Ruiz","James Stevermer","Joel Tsevat","Sandra Millon Underwood","John B Wong"],"significance":7,"published":"2023-09-19","source_date":"2023-09-19","image":"","kennis":["https://hartvaat.nl/kennis/hypertensie/hypertensie-en-zwangerschap/","https://hartvaat.nl/kennis/farmacologie/betablokkers-cardiale-indicaties/"],"congress":"","summary_en":"The USPSTF reaffirmed the recommendation to screen for hypertensive disorders at every prenatal visit, reflecting the rising incidence of preeclampsia and gestational hypertension as leading causes of maternal morbidity.","created":"2026-07-03T10:30:34Z","updated":"2026-07-03T13:29:37Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"De USPSTF bevestigde de aanbeveling voor bloeddrukscreening bij elke prenatale controle om hypertensieve zwangerschapsstoornissen vroegtijdig te detecteren. Pre-eclampsie is een leidende oorzaak van maternale morbiditeit en sterfte.","abstract_original":"IMPORTANCE: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017. OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. POPULATION: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. RECOMMENDATION: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation)."}